Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wakeling

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Steroids|July 1, 1989
Novel steroidal pure antiestrogensJ Bowler, T J Lilley, J D Pittam, et al.
Molecular and Cellular Probes|February 12, 1998
A common polymorphism in exon 16 of the human insulin-like growth factor-1 receptor gene (IGF1R)S Abu-Amero, M Preece, E Wakeling, et al.
Journal of Steroid Biochemistry|July 1, 1989
Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cellsL R Wiseman, A E Wakeling, F E May, et al.
Journal of Steroid Biochemistry|December 1, 1981
Receptor binding and biological activity of steroidal and nonsteroidal antiandrogensA E Wakeling, B J Furr, A T Glen, et al.
Journal of Steroid Biochemistry|March 1, 1990
A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the molybdate-stabilized oestrogen receptorA P Wilson, P J Weatherill, R I Nicholson, et al.
Journal of Steroid Biochemistry|January 1, 1988
Interaction of the antioestrogen ICI 164,384 with the oestrogen receptorP J Weatherill, A P Wilson, R I Nicholson, et al.
International Journal of Cancer|May 16, 1995
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damageJ W Wilson, A E Wakeling, I D Morris, et al.
Breast Cancer Research and Treatment|September 21, 2004
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cellsNicola J Jordan, Julia M W Gee, Denise Barrow, et al.
Journal of the National Cancer Institute|June 17, 2004
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJiang Shou, Suleiman Massarweh, C Kent Osborne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growthC K Osborne, M Jarman, R McCague, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Steroids|July 1, 1989
Novel steroidal pure antiestrogensJ Bowler, T J Lilley, J D Pittam, et al.
Molecular and Cellular Probes|February 12, 1998
A common polymorphism in exon 16 of the human insulin-like growth factor-1 receptor gene (IGF1R)S Abu-Amero, M Preece, E Wakeling, et al.
Journal of Steroid Biochemistry|July 1, 1989
Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cellsL R Wiseman, A E Wakeling, F E May, et al.
Journal of Steroid Biochemistry|December 1, 1981
Receptor binding and biological activity of steroidal and nonsteroidal antiandrogensA E Wakeling, B J Furr, A T Glen, et al.
Journal of Steroid Biochemistry|March 1, 1990
A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the molybdate-stabilized oestrogen receptorA P Wilson, P J Weatherill, R I Nicholson, et al.
Journal of Steroid Biochemistry|January 1, 1988
Interaction of the antioestrogen ICI 164,384 with the oestrogen receptorP J Weatherill, A P Wilson, R I Nicholson, et al.
International Journal of Cancer|May 16, 1995
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damageJ W Wilson, A E Wakeling, I D Morris, et al.
Breast Cancer Research and Treatment|September 21, 2004
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cellsNicola J Jordan, Julia M W Gee, Denise Barrow, et al.
Journal of the National Cancer Institute|June 17, 2004
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJiang Shou, Suleiman Massarweh, C Kent Osborne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growthC K Osborne, M Jarman, R McCague, et al.
Pageof 9